About

To improve the quality of life for those affected by schizophrenia & psychosis through education, support programs, public policy & research.

Capabilities
  • Desktop Display
    • Brand Integrations
      Yes No
    • Sponsored Posts
      Yes No
    • Native Ads
      Yes No
    • High-Impact (Takeovers, Billboards, Overlays, Sliders, Skins)
      Yes No
    • Rich Media (Expandable & Non-Expandable)
      Yes No
  • Mobile Display
    • Mobile Rich Media (Including Interstitials & Expandables)
      Yes No
    • Tablet Traffic
      Yes No
    • Native & Custom Mobile Executions
      Yes No
    • Requires SDK Integration
      Yes No
  • Email
  • Social
  • Desktop Display, Mobile Display, Email, Social
  • CPM
  • Web Publisher
  • Headline:
    Publisher
  • Key Differentiator
    Started in 1995, Schizophrenia.com is an internet community dedicated to providing high quality information, support and education to the family members, caregivers and individuals whose lives have been impacted by schizophrenia. This web community was founded in memory of John Chiko, who suffered from schizophrenia. We are dedicated to improving the lives of all individuals and families suffering from schizophrenia, and in speeding the research progress towards a cure. Executive Director: Brian Chiko, BSc, University of Santa Clara Editor: J. Megginson Hollister, PhD, Clinical Psychology, University of Southern California, Post-doctoral Fellowships, University of Pennsylvania and University of Utrecht, Departments of Psychiatry. Pre-Doctoral Clinical Psychology work at Harvard University affiliated Brockton VA Hospital, Brockton, MA. Writers and Contributors Erin Hawkes, MSc, Neuroscience, University of British Columbia. You can purchase Erin’s book here: When Quietness Came: A Neuroscientist’s Personal Journey with Schizophrenia. Past Writers and Contributors Demian Rose, MD, PhD, Psychiatry – University of California, San Francisco, School of Medicine. Brian J. Schulman, Candidate for Doctor of Medicine, Psychiatry, University of California, San Francisco, School of Medicine. Marvin Ross, Science writer – freelance Michelle Roberts, Masters in Psychology Candidate, BSc, Psychology, Santa Clara University. Jennifer Barnett, PhD, Psychiatry, Post-Doctoral Research Associate, University of Cambridge, Department of Psychiatry, England. Leslie Yan Meier, PhD Candidate, Clinical Psychology, University of California, Los Angeles. Jacob Ballon, MD, Resident in Psychiatry, Stanford University Medical School. Farzin Irani, PhD Candidate, Neuropsychology, Drexel University Julia Dobervich, Candidate for Doctor of Medicine, University of Texas, Southwestern The site is managed by a group of independent volunteers and contractors around the world – most of whom are either family members (with sons and daughters, brothers and sisters, or parents who have suffered from schizophrenia) or people who have schizophrenia. While most of our writers are students of psychiatry, psychology and neuroscience, for the most part we are not full-time working mental health professionals but we are very familiar with the disease both through direct personal experience and extensive reading on the topic. We rely upon what we believe are good sources of scientifically accurate materials relating to schizophrenia and frequently consult with an ever growing group of schizophrenia researchers who act as unofficial advisors to the site. We owe a great debt of gratitude to the schizophrenia researchers who help on an unofficial basis by answering our questions and occasionally providing feedback on different areas of the site, and these researchers include (but are not limited to) the following: Thomas McGlashan, MD and Scott Woods, MD, Yale University School of Medicine (Psychiatry) Irv Gottesman, PhD, – Professor Emeritus of University of Virginia E. Fuller Torrey, PhD – Stanley Medical Research Institute Ann Pulver, ScD – Johns Hopkins Medical School And many others… who periodically send us news on new research or added information that we should be aware of. While we greatly appreciate the occasional input from these experts, if you find any mistakes, misspellings or typographical errors on the web site they are, or course, entirely our responsibility. We welcome email that identifies any errors that you identify on the web site. Additionally, we are always looking for additional sources of expert opinion, and we welcome suggestions for improvement to the site. We have no formal affiliations with any other mental health-related organizations or companies. We don’t advocate any one program of treatment, but we try to provide strong, science-based information (both the good and the bad news) on all the options available so that people can discuss things with their doctors and make the best informed decisions for themselves and their families. We avoid simplistic answers because we know from experience that this is a very complex disease. We do not claim to provide any medical recommendations at this site, we just provide information for your consideration and possible use in consultation with qualified psychologists and psychiatrists. Schizophrenia.com is a place where family members, friends, people with schizophrenia, researchers, and other professionals come together to share information and experiences in the common battle against this disease. See the following link for our Privacy Policy Following are the key objectives of this site: Primary Objective To quickly improve the lives of individuals and families suffering from schizophrenia by providing high quality (science-based) information, as well as support and education, research and discussions on all relevant topics. Secondary Objectives To more widely and quickly disseminate schizophrenia research and information so that treatment techniques, medications or cures can more rapidly be identified and adopted so that the lives of people with schizophrenia are more quickly improved. To facilitate communication between the different schizophrenia “stakeholders” – i.e. the schizophrenia research groups, the support organizations and the families around the world suffering from schizophrenia – so as to improve the understanding and flow of mutually beneficial information between all of the groups. To create a comprehensive Schizophrenia Information service, and to make this service available to as broad an audience as possible, so as to maximize the benefit that this information will have to people around the world. The overall goal of this web site is to provide valuable, timely and accurate information on schizophrenia. We hope that it will be of value to you.
Site Traffic
  • 177831 Global Rank
  • 51295
    United States
  • 198 K Estimated Visits
Traffic Sources
  • Direct
    61.65%
  • Search
    28.66%
  • Referrals
    7.80%
  • Social
    1.05%
  • Mail
    0.84%
  • Display
    0.00%
Geography Breakdown
Powered by
Alexa Traffic Data
Global Rank 122,030
1,121
United States Rank 28,158
38,415
United States Page Views 96.9%
11.5%
Top Countries
Top Search Keywords
  • Disorders
  • Schizophrenia
Ad Intelligence
  • Standard
    100.00%
Ads Seen Recently
23
Latest Advertisers
Longest Running Ad
Schizophrenia
Device
Desktop
Dimensions
other
Schizophrenia
Device
Mobile
Dimensions
728x90
Schizophrenia
Device
Desktop
Dimensions
160x600
Schizophrenia
Device
Desktop
Dimensions
728x90
Schizophrenia
Device
Desktop
Dimensions
728x90
Schizophrenia
Device
Mobile
Dimensions
728x90
Schizophrenia advertising reaches 198k visitors across desktop and mobile web, in countries such as United States, Norway, India, Canada, Malaysia, United Kingdom, Australia. Pricing models they offer are CPM on channels such as Display, Mobile, Email, Social Advertising on Schizophrenia will allow you to reach consumers in industries or verticals such as .

They have 1 advertising & marketing contacts listed on Kochava.

Schizophrenia works with Advertising technology companies such as Google Adsense, Google Publisher Tag, DoubleClick.Net, Open AdStream, Amazon Associates, Google AdSense Custom Search Ads, Google AdSense Integrator, Atlas, Ad Delivery Solutions, FLoC, Twitter Ads.